SCHEMBL5871635

SCHEMBL5871635

O=CC1CCN(CCc2ccccc2F)CC1

nearest known ligand 0.46

Predicted protein targets (top 19)

geneUniProtsupporting neighboursconfidence
HTR2A P28223 7/20 0.46
KCNH2 Q12809 6/20 0.46
HTR2C P28335 5/20 0.46
DRD2 P14416 3/20 0.46
OPRM1 P35372 5/20 0.46
OPRD1 P41143 1/20 0.46
OPRK1 P41145 1/20 0.46
MAOA P21397 1/20 0.46
MAOB P27338 1/20 0.46
CACNA1G O43497 1/20 0.46
SIGMAR1 Q99720 3/20 0.44
HTR7 P34969 1/20 0.43
HTR6 P50406 1/20 0.43
CARM1 Q86X55 1/20 0.43
PRMT6 Q96LA8 1/20 0.43
ATM Q13315 1/20 0.43
GRM2 Q14416 1/20 0.42
HTR1A P08908 1/20 0.42
SLC6A4 P31645 1/20 0.42

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL28552309 0.85 ATM (0.58) DRD2SIGMAR1ATM
SCHEMBL3589864 0.80 MAOA (0.52) HTR2AKCNH2HTR2CDRD2OPRM1
Ammonia Solution, Strong SCHEMBL27785552 0.79 ACHE (0.59) KCNH2OPRM1MAOAMAOBCACNA1G
Methane SCHEMBL3600037 0.79 MAOA (0.51) HTR2AKCNH2HTR2CDRD2OPRM1
SCHEMBL7829844 0.78 ACHE (0.63) HTR2AKCNH2HTR2CSIGMAR1
SCHEMBL3600033 0.78 CXCR4 (0.54) HTR2AKCNH2HTR2CDRD2MAOA
SCHEMBL9556728 0.77 CACNA1G (0.54) HTR2AHTR2COPRM1MAOAMAOB
Hydrochloric Acid SCHEMBL27678283 0.77 ACHE (0.61) HTR2AKCNH2HTR2CSIGMAR1
SCHEMBL27785549 0.77 CARM1 (0.55) HTR2AKCNH2HTR2CDRD2OPRM1
SCHEMBL17842157 0.76 KDM4E (0.53) DRD2HTR7HTR6HTR1A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 9 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-7071201-B2 Serotonin antagonism; muscle relaxant for myotonia; such as 1-(1-(2-(4-methoxyphenyl)ethyl)piperidin-4-yl)-7-methoxy-1,2,3,4 -tetrahydroquinoline EISAI CO., LTD. (JP) 2006-07-04 US disclosed
EP-0976732-B1 1,4-SUBSTITUTED CYCLIC AMINE DERIVATIVES EISAI CO LTD (JP) 2004-11-24 EP disclosed
US-6579881-B2 Indoles EISAI CO., LTD. (JP) 2003-06-17 US disclosed
US-6448243-B1 SEROTONIN ANTAGONIST FOR TREATING, AMELIORATING AND PREVENTING SPASTIC PARALYSIS OR CENTRAL MUSCLE RELAXANTS FOR AMELIORATING MYOTONIA EISAI CO., LTD. (JP) 2002-09-10 US disclosed
US-20020086999-A1 Certain quinoline derivatives EISAI CO., LTD. 2002-07-04 US disclosed
US-20020019531-A1 Indoles EISAI CO., LTD. 2002-02-14 US disclosed
EP-0976732-A1 1,4-SUBSTITUTED CYCLIC AMINE DERIVATIVES Eisai Co., Ltd. (JP) 2000-02-02 EP disclosed
EP-0626968-A4 1995-01-04 EP disclosed
EP-0626968-A1 PIPERIDINYL THIACYCLIC DERIVATIVES MERRELL PHARMACEUTICALS INC. (US) 1994-12-07 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20020019531-A1 Indoles INMT, MUSK, MB HTR2A 209/4885KCNH2 432/4885HTR2C 222/4885
US-20020086999-A1 Certain quinoline derivatives CHRM1, CHRNA5, CHRNA4 HTR2A 143/4885KCNH2 309/4885HTR2C 107/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.